Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andreas Boehle, MD
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck
Study Chair - Christoph Zielinski, MD
Allgemeines Krankenhaus - Universitatskliniken
Study Chair - David C. Smith, MD
University of Michigan Rogel Cancer Center
Study Chair - Jose Baselga, MD
Vall d'Hebron University Hospital
Study Chair - Malcolm J. Moore, MD
Princess Margaret Hospital, Canada
Study Chair - Michael Leahy, MBChB, FRACP, FRCP, FRC Path
Fremantle Hospital
Study Chair - Stephane Culine, MD
Institut du Cancer de Montpellier - Val d'Aurelle
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
234 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fremantle Hospital
Fremantle, Western Australia, Australia
- Kaiser Franz Josef Hospital
Vienna, Austria
- Onze Lieve Vrouw Ziekenhuis Aalst
Aalst, Belgium
- Academisch Ziekenhuis Der Vrije Universiteit Brussel
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Universitair Ziekenhuis Antwerpen
Edegem, Belgium
- Chu Liege - Domaine Universitaire Du Sart Tilman
Liège, Belgium
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Lethbridge Cancer Clinic
Lethbridge, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Nanaimo Cancer Clinic at Nanaimo Regional General Hospital
Nanaimo, British Columbia, Canada
- Lions Gate Hospital
North Vancouver, British Columbia, Canada
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Prostate Centre at Vancouver General Hospital
Vancouver, British Columbia, Canada
- Providence Health Care - Vancouver
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
- G. Steinhoff Clinical Research
Victoria, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Doctor Leon Richard Oncology Centre
Moncton, New Brunswick, Canada
- Moncton Hospital
Moncton, New Brunswick, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Newfoundland Cancer Treatment and Research Foundation
St. John's, Newfoundland and Labrador, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Cape Breton Cancer Centre
Sydney, Nova Scotia, Canada
- Royal Victoria Hospital, Barrie
Barrie, Ontario, Canada
- William Osler Health Centre
Brampton, Ontario, Canada
- Northeastern Ontario Regional Cancer Centre - Sudbury
Greater Sudbury, Ontario, Canada
- Hamilton and District Urology Association
Hamilton, Ontario, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Kingston Regional Cancer Centre
Kingston, Ontario, Canada
- Grand River Regional Cancer Centre
Kitchner, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Markham Stouffville Hospital
Markham, Ontario, Canada
- Credit Valley Hospital
Mississauga, Ontario, Canada
- Trillium Health Centre
Mississauga, Ontario, Canada
- Southlake Regional Health Centre
Newmarket, Ontario, Canada
- North York General Hospital, Ontario
North York, Ontario, Canada
- Sunnybrook and Women'S College Health Sciences Centre
North York, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2001
- Primary completion
- 30 Jun 2004
- Completion
- —
- Last update posted
- 12 Jun 2013
- Registered enrollment
- 608
- Registry id
- NCT00022191
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.